Salicylic Acid

Salicylic Acid at a Glance

Salicylic acid, or 2-hydroxybenzoic acid, is a simple phenolic acid found throughout the plant kingdom. In plants it acts as a defence and stress-signalling hormone; in people it is best known as a topical keratolytic that helps shed thickened, scaling or clogged skin. In dermatology and skincare it is usually classed as a beta-hydroxy acid.

It is closely related to aspirin but not interchangeable with it. Aspirin is acetylsalicylic acid, a synthetic derivative whose added acetyl group gives it far stronger, irreversible effects on cyclo-oxygenase enzymes; salicylic acid is aspirin’s weaker deacetylated metabolite ^{3,4Reference 3Mitchell JA et al. · 1997Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acidView study →Reference 4Klessig DF et al. · 2016Multiple targets of salicylic acid and its derivatives in plants and animalsView study →}.

Its clearest medical role is topical — decades of established dermatological use for acne, warts, psoriasis, dandruff and other conditions involving excessive or disordered skin-cell buildup ^{5,10Reference 5Huber C · 1977Huber C, Christophers E (1977). “Keratolytic” effect of salicylic acid. Archives of Dermatological Research. https://pubmed.ncbi.nlm.nih.gov/319767/View study →Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →}. Its systemic anti-inflammatory reputation, by contrast, is largely borrowed from aspirin and from whole willow-bark extract rather than demonstrated for the free acid itself ^{6,7Reference 6Nahrstedt A et al. · 2007Willow bark extract: the contribution of polyphenols to the overall effectView study →Reference 7Chrubasik S et al. · 2000RCTTreatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyView study →}.

Established Medical Uses

Salicylic acid’s primary human use is as a topical keratolytic: it weakens the connections between cells in the outermost layer of skin, allowing thickened, scaling or clogged tissue to shed more easily ^{5Reference 5Huber C · 1977Huber C, Christophers E (1977). “Keratolytic” effect of salicylic acid. Archives of Dermatological Research. https://pubmed.ncbi.nlm.nih.gov/319767/View study →}. Depending on concentration and formulation, it is used for:

• Acne and clogged pores
• Warts and verrucae
• Psoriasis and other hyperkeratotic conditions
• Dandruff and seborrhoeic dermatitis
• Corns, calluses and other thickened skin
• Professional chemical peels

Although keratolytic is the usual term, salicylic acid does not simply dissolve keratin. It acts more precisely as a desmolytic — disrupting the corneodesmosomes and desmosomal proteins that hold corneocytes together, while leaving the keratin inside those cells largely intact ^{5,10Reference 5Huber C · 1977Huber C, Christophers E (1977). “Keratolytic” effect of salicylic acid. Archives of Dermatological Research. https://pubmed.ncbi.nlm.nih.gov/319767/View study →Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →}. This topical role rests on decades of established dermatological use; the oral anti-inflammatory, analgesic and antioxidant claims below are considerably less direct.

Salicylic Acid vs. Aspirin

Salicylic acid and aspirin belong to the same chemical family but are different compounds with different pharmacology — and conflating them is the single most common error about this molecule.

Aspirin is acetylsalicylic acid. Its added acetyl group lets it irreversibly modify cyclo-oxygenase enzymes, particularly COX-1 — the mechanism behind aspirin’s established analgesic, anti-inflammatory, antipyretic and antiplatelet effects.

Salicylic acid is the deacetylated metabolite formed after aspirin is absorbed. It interacts with cyclo-oxygenase only weakly and reversibly, and its effect can be displaced by arachidonic acid; it does not reproduce aspirin’s irreversible COX acetylation or its antiplatelet activity ^{3Reference 3Mitchell JA et al. · 1997Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acidView study →}. At higher concentrations it may still influence inflammation through NF-κB / IKKβ signalling, but its systemic anti-inflammatory reputation is more often borrowed from aspirin or whole willow than shown for the oral isolated acid ^{3,4Reference 3Mitchell JA et al. · 1997Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acidView study →Reference 4Klessig DF et al. · 2016Multiple targets of salicylic acid and its derivatives in plants and animalsView study →}.

The practical distinction is worth holding onto:

• Aspirin — an established systemic drug.
• Salicylic acid — an established topical drug.
• Willow bark — a chemically complex botanical extract whose effects cannot be reduced to salicylic acid alone ^{6,7Reference 6Nahrstedt A et al. · 2007Willow bark extract: the contribution of polyphenols to the overall effectView study →Reference 7Chrubasik S et al. · 2000RCTTreatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyView study →}.

What It's Used For

Beyond its established topical use, salicylic acid’s systemic pharmacology is modest and frequently mis-attributed. The evidence splits sharply by route, and by whether the isolated molecule — rather than aspirin or whole willow — was the thing actually tested.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Scores mix a genuinely well-evidenced topical drug use with thin plant-constituent data, so read the per-row basis.

01Keratolytic / dermatological (topical)Promising58%Decades of topical clinical use + defined desmolytic mechanism ^{5,10Reference 5Huber C · 1977Huber C, Christophers E (1977). “Keratolytic” effect of salicylic acid. Archives of Dermatological Research. https://pubmed.ncbi.nlm.nih.gov/319767/View study →Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →}

02Anti-inflammatory / analgesic (salicylate)Shaky36%Non-acetylated salicylate; COX-2/NF-κB mechanism, but efficacy belongs to aspirin & whole willow ^{3,4,6Reference 3Mitchell JA et al. · 1997Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acidView study →Reference 4Klessig DF et al. · 2016Multiple targets of salicylic acid and its derivatives in plants and animalsView study →Reference 6Nahrstedt A et al. · 2007Willow bark extract: the contribution of polyphenols to the overall effectView study →}

03Antioxidant (phenolic fraction)Shaky26%In-vitro, as an extract constituent (horsetail, P. vicina) ^{1,2Reference 1Mimica-Dukić N et al. · 2008Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidantsView study →Reference 2Zhang Z et al. · 2022Characterization, antioxidant activities, and pancreatic lipase inhibitory effect of extract from the edible insect Polyrhachis vicinaView study →}

Mechanisms

The COX contrast is the load-bearing point: the free acid’s feeble, reversible COX inhibition is exactly why aspirin (which acetylates COX) — not salicylic acid — carries the antiplatelet/anti-inflammatory drug record. The plant-hormone role ^{4Reference 4Klessig DF et al. · 2016Multiple targets of salicylic acid and its derivatives in plants and animalsView study →} is real biology but off the human-pharmacology axis.

Pharmacokinetics

Salicylic acid is a small, lipophilic aromatic acid, so it is well absorbed orally and binds extensively to plasma albumin. Its hepatic metabolism — conjugation to salicyluric acid and to phenolic/acyl glucuronides — is saturable: above roughly 20–30 mg/dL these pathways are overwhelmed, elimination shifts from first-order to zero-order, and the half-life climbs from ~2–3 h at therapeutic exposure to 20–40 h in overdose ^{12Reference 12Sidlak AM et al. · 2025ReviewAcute salicylate toxicity: a narrative review for emergency cliniciansView study →}. This non-linear kinetics is central to why salicylate poisoning escalates. Topically, percutaneous absorption through intact skin is limited, but it rises sharply across broken, diseased or occluded skin, large body-surface application, or in children, where enough can be absorbed to reach toxic plasma levels ^{10,11Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →Reference 11Davies MG et al. · 1979Systemic toxicity from topically applied salicylic acidView study →}. Distinctively for this molecule, there is a measurable endogenous/dietary background: salicylic acid circulates in aspirin-free humans, partly from food and partly biosynthesised in vivo from benzoic acid ^{8Reference 8Paterson JR et al. · 2008Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acidView study →}.

Clinical trials

Human evidence splits cleanly by route. Topical salicylic acid is an established, extensively-used keratolytic drug (OTC dermatological monograph) — that is its real clinical footprint ^{10Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →}. There are no modern trials of oral isolated salicylic acid as a systemic drug (aspirin superseded it, and the free acid is more gastric-irritant); herbal human data belong to whole willow-bark extract, e.g. a randomised placebo-controlled low-back-pain trial standardised to salicin ^{7Reference 7Chrubasik S et al. · 2000RCTTreatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyView study →}, within which free salicylic acid is only a minor metabolite ^{6Reference 6Nahrstedt A et al. · 2007Willow bark extract: the contribution of polyphenols to the overall effectView study →}.

Last checked: July 2026.

Isolate vs. Plant Studies

This molecule inverts the usual isolate-vs-plant caveat. Topically, the isolate is the evidence — salicylic acid is used and studied as a pure keratolytic drug at defined concentrations, a genuine strength ^{5,10Reference 5Huber C · 1977Huber C, Christophers E (1977). “Keratolytic” effect of salicylic acid. Archives of Dermatological Research. https://pubmed.ncbi.nlm.nih.gov/319767/View study →Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →}. Systemically, the opposite holds: the free acid is not run as a stand-alone oral drug, so its anti-inflammatory reputation is borrowed from two different things — aspirin, the synthetic acetyl ester with the real analgesic/antiplatelet record, and whole willow-bark extract, whose randomised human evidence is for the standardised extract, not the metabolite ^{7Reference 7Chrubasik S et al. · 2000RCTTreatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyView study →}. Indeed, plasma salicylic acid after willow dosing is too low to account for the extract’s effect, pointing to co-acting polyphenols and flavonoids ^{6Reference 6Nahrstedt A et al. · 2007Willow bark extract: the contribution of polyphenols to the overall effectView study →}. As an antioxidant plant/insect-extract constituent (horsetail, P. vicina, celandine, marshmallow) it is always one phenolic among many in whole-extract in-vitro assays, seldom isolated ^{1,2Reference 1Mimica-Dukić N et al. · 2008Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidantsView study →Reference 2Zhang Z et al. · 2022Characterization, antioxidant activities, and pancreatic lipase inhibitory effect of extract from the edible insect Polyrhachis vicinaView study →}.

Its Role in Plants

In plants, salicylic acid is not a passive phytochemical but an important defence and stress-signalling hormone. Its best-known function is in systemic acquired resistance: when one part of a plant is infected or wounded, salicylic-acid signalling helps switch on protective responses in distant tissues, priming the whole organism against further attack ^{4Reference 4Klessig DF et al. · 2016Multiple targets of salicylic acid and its derivatives in plants and animalsView study →}.

More than two dozen plant salicylic-acid-binding proteins have been identified, linking the molecule to pathogen defence, systemic acquired resistance, seed germination, stomatal closure, thermogenesis, and responses to drought and heat ^{4Reference 4Klessig DF et al. · 2016Multiple targets of salicylic acid and its derivatives in plants and animalsView study →}.

These are plant-biology functions and should not be read as human pharmacology — a molecule’s role as a plant hormone does not predict what it does as a medicine.

Prevalence in Nature

Salicylic acid occurs widely across the plant kingdom, though the free acid is usually present at low concentrations. It appears as a phenolic-acid-fraction constituent of willow bark (Salix), meadowsweet (Filipendula ulmaria), field horsetail (Equisetum arvense) ^{1Reference 1Mimica-Dukić N et al. · 2008Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidantsView study →}, marshmallow (Althaea officinalis) and greater celandine (Chelidonium majus); wintergreen carries it in the form of methyl salicylate. In willow, most of the eventual salicylic acid is generated from the glycoside salicin rather than stored as the pre-formed acid.

Some culinary spices carry much more than most herbs — up to ~1.5 wt% — and eating salicylate-rich foods raises serum levels measurably ^{15Reference 15Paterson JR et al. · 2006Salicylic acid content of spices and its implicationsView study →}. The molecule is not confined to plants either: it is a major polyphenol of the edible ant Polyrhachis vicina extract ^{2Reference 2Zhang Z et al. · 2022Characterization, antioxidant activities, and pancreatic lipase inhibitory effect of extract from the edible insect Polyrhachis vicinaView study →}.

Most strikingly, salicylic acid is partly endogenous in animals and humans. It circulates in people who have never taken aspirin — reflecting both dietary intake and biosynthesis in vivo from benzoic acid — persists in plasma during prolonged fasting, and in drug-free vegetarians can reach serum levels overlapping those of patients on low-dose aspirin, though far below therapeutic aspirin exposure ^{8Reference 8Paterson JR et al. · 2008Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acidView study →}.

Discovery & Synthesis

The molecule was first isolated in 1838 by the Italian chemist Raffaele Piria (working in Paris), who obtained “acido salicilico” by oxidising salicin, the willow/meadowsweet glucoside earlier named by Fontana and Buchner — the culmination of a chain of nineteenth-century Italian and German salicylate chemistry ^{9Reference 9Marson P · 2006Marson P, Pasero G (2006). [The Italian contributions to the history of salicylates]. Reumatismo. https://pubmed.ncbi.nlm.nih.gov/16639491/View study →}. Two decades later the compound moved from extraction to manufacture: Hermann Kolbe and Rudolf Schmitt developed a total synthesis (the Kolbe–Schmitt carboxylation) around 1859, and Friedrich von Heyden industrialised it in 1874, making synthetic salicylic acid far cheaper than willow extract ^{13Reference 13Ozleyen A et al. · 2023Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and preventionView study →}. Because the free acid was harshly irritating to the stomach, Felix Hoffmann at Bayer acetylated it in 1897 to acetylsalicylic acid — aspirin — the better-tolerated derivative that became the dominant salicylate drug ^{13Reference 13Ozleyen A et al. · 2023Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and preventionView study →}; the free acid, meanwhile, kept its own niche as a topical keratolytic. Manufacture today is overwhelmingly synthetic: the Kolbe–Schmitt reaction of sodium phenoxide with carbon dioxide remains the industrial route, so commercial salicylic acid is a made molecule, not a plant extract.

Patents: not yet researched.

Toxicity & Safety

Salicylic acid carries a moderate flag — higher than a typical plant phenolic — because it is a bona-fide salicylate: in enough systemic quantity it produces salicylism, and it is more gastric-irritant by mouth than aspirin. The caveats below are salicylate-class cautions applied to the free acid.

Safety at a Glance

⚠️ Moderate toxicity

• Well-established topical keratolytic. Decades of dermatological use for acne, warts, psoriasis and dandruff at defined concentrations.
• Salicylism from systemic exposure. Tinnitus, nausea/vomiting, hyperventilation and a mixed respiratory-alkalosis / metabolic-acidosis picture from mitochondrial uncoupling — including after heavy topical use.
• Topical absorption is not zero. Broken/diseased skin, large treated areas, occlusion and children raise systemic absorption toward toxic levels.
• Salicylate-class cautions. Aspirin allergy, salicylate sensitivity (AERD), GI irritation, and the theoretical Reye’s-syndrome concern in children with viral illness all carry over.

Full Safety & Interactions Detail

Acute salicylate toxicity (salicylism). At toxic systemic concentrations salicylic acid uncouples mitochondrial oxidative phosphorylation and disrupts the citric-acid cycle, producing the characteristic tinnitus, nausea/vomiting, hyperpnoea, and the mixed respiratory alkalosis plus anion-gap metabolic acidosis of salicylate poisoning; severe cases progress to altered mental status, seizures, pulmonary oedema and require alkalinisation and, if severe, haemodialysis ^{12Reference 12Sidlak AM et al. · 2025ReviewAcute salicylate toxicity: a narrative review for emergency cliniciansView study →}. The saturable, non-linear kinetics (see Pharmacokinetics) mean toxicity escalates disproportionately once metabolism is overwhelmed ^{12Reference 12Sidlak AM et al. · 2025ReviewAcute salicylate toxicity: a narrative review for emergency cliniciansView study →}.

Topical → systemic route. Salicylic acid is one of the few “cosmetic” acids that can poison via the skin: percutaneous absorption is minimal through intact skin but rises sharply across broken, inflamed or occluded skin, over large body-surface areas, and in children. Case reports and a dedicated review document systemic salicylism — including encephalopathy and severe acid-base disturbance — from topical preparations, so extensive or high-strength topical use warrants the same caution as an oral salicylate ^{10,11Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →Reference 11Davies MG et al. · 1979Systemic toxicity from topically applied salicylic acidView study →}.

GI and general. Taken internally, the free acid is more irritating to the stomach than aspirin and offers no advantage as a systemic anti-inflammatory. It carries the general salicylate contraindications: aspirin/salicylate allergy, and salicylate sensitivity — in aspirin-exacerbated respiratory disease (AERD) even dietary salicylates can aggravate symptoms, and a low-salicylate diet has been trialled for this population ^{14Reference 14Sowerby LJ et al. · 2021RCTEffect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease — a randomized crossover trialView study →}. The class-wide Reye’s-syndrome association means salicylates are avoided in children and teenagers with viral illness (chickenpox, influenza); this risk is chiefly documented for aspirin/the salicylate class rather than proven for topical salicylic acid, but the caution is applied conservatively.

Reproductive note (prose only). No dedicated reproductive-toxicity dataset exists for isolated plant/topical salicylic acid; systemic salicylate exposure in pregnancy is generally cautioned at the drug level. Pregnancy/lactation decisions belong to the herb or product page where intake is decided, not to this molecule page. No comprehensive isolate genotoxicity/repeat-dose package is characterised here for the pure compound beyond the salicylate-class toxicology above.

Dosage

There is no recommended systemic oral dose for isolated salicylic acid — it is more gastric-irritant than aspirin and is not used as a stand-alone oral drug. Its established dosing is entirely topical, with the concentration chosen for the condition and formulation ^{10Reference 10Madan RK · 2014ReviewA review of toxicity from topical salicylic acid preparationsView study →}:

Higher concentrations are not simply stronger versions of everyday skincare — they can cause significant irritation or chemical burns and are generally reserved for limited-area or professional use. Herbal exposure is indirect: willow-bark products are standardised to salicin (commonly 120–240 mg/day in research), not to free salicylic acid ^{6,7Reference 6Nahrstedt A et al. · 2007Willow bark extract: the contribution of polyphenols to the overall effectView study →Reference 7Chrubasik S et al. · 2000RCTTreatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyView study →}, and dietary/endogenous exposure sits at low background levels ^{8,15Reference 8Paterson JR et al. · 2008Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acidView study →Reference 15Paterson JR et al. · 2006Salicylic acid content of spices and its implicationsView study →}. These are established topical concentrations and research figures, not a personal recommendation.

References

1. Mimica-Dukić N, et al. (2008). Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants. Molecules. https://pubmed.ncbi.nlm.nih.gov/18719517/
2. Zhang Z, et al. (2022). Characterization, antioxidant activities, and pancreatic lipase inhibitory effect of extract from the edible insect Polyrhachis vicina. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/35464030/
3. Mitchell JA, et al. (1997). Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Molecular Pharmacology. https://pubmed.ncbi.nlm.nih.gov/9187256/
4. Klessig DF, Tian M, Choi HW (2016). Multiple targets of salicylic acid and its derivatives in plants and animals. Frontiers in Immunology. https://pubmed.ncbi.nlm.nih.gov/27303403/
5. Huber C, Christophers E (1977). “Keratolytic” effect of salicylic acid. Archives of Dermatological Research. https://pubmed.ncbi.nlm.nih.gov/319767/
6. Nahrstedt A, et al. (2007). Willow bark extract: the contribution of polyphenols to the overall effect. Wiener Medizinische Wochenschrift. https://pubmed.ncbi.nlm.nih.gov/17704985/
7. Chrubasik S, et al. (2000). Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. The American Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/10936472/
8. Paterson JR, et al. (2008). Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acid. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/19053387/
9. Marson P, Pasero G (2006). [The Italian contributions to the history of salicylates]. Reumatismo. https://pubmed.ncbi.nlm.nih.gov/16639491/
10. Madan RK, Levitt J (2014). A review of toxicity from topical salicylic acid preparations. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/24472429/
11. Davies MG, et al. (1979). Systemic toxicity from topically applied salicylic acid. British Medical Journal. https://pubmed.ncbi.nlm.nih.gov/435713/
12. Sidlak AM, et al. (2025). Acute salicylate toxicity: a narrative review for emergency clinicians. Cureus. https://pubmed.ncbi.nlm.nih.gov/41049912/
13. Ozleyen A, et al. (2023). Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention. Journal of Cancer Research and Clinical Oncology. https://pubmed.ncbi.nlm.nih.gov/35876951/
14. Sowerby LJ, et al. (2021). Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease — a randomized crossover trial. Journal of Otolaryngology - Head & Neck Surgery. https://pubmed.ncbi.nlm.nih.gov/33892819/
15. Paterson JR, et al. (2006). Salicylic acid content of spices and its implications. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/16608205/

View all 15 references▾